Doi.org/10.1002/art.10674

Target Article

Infliximab in primary Sjögren's syndrome: one-year followup  ; Serge D Steinfeld Paul Demols Thierry Appelboom; NULL; 12/01/2012; https://doi.org/10.1002/art.10674

Reasons

Note: Reasons not yet here included, but you are welcome to insert this information whenever you wish.